<DOC>
	<DOCNO>NCT02837744</DOCNO>
	<brief_summary>To evaluate Safety Efficacy Axiostat® hemostatic dressing compare Standard Institutional Care product term time achieve hemostasis , post application complication comfort level patient .</brief_summary>
	<brief_title>Studying Hemostatic Effect Axiostat® Dressing Radial Access After Percutaneous Procedure</brief_title>
	<detailed_description>To evaluate Safety Efficacy Axiostat® hemostatic dressing compare Standard Institutional Care product term time achieve hemostasis , post application complication comfort level patient undergone radial intervention .</detailed_description>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>1 . Age great equal 18 year . 2 . Patient and/or patient 's legal representative and/or impartial witness has/have inform nature study agree provision provide write informed consent approve Ethics Committee investigative site . 3 . Iatrogenic puncture 4 . Patient want undergo radial intervention . 5 . All puncture size must less 2.5cm . 1 . Prior diagnosis disease medical condition affect ability blood clot ( e.g. , hemophilia. ) . 2 . Patients know sensitivity chitosan ( shellfish ) use study . 3 . Patients , opinion Investigator , may complete study reason , e.g . Patient require Immediate suturing . 4 . Patient currently participate investigational drug dress study yet complete primary endpoint interfere procedure assessment trial . 5 . Pregnant woman . 6 . Patients hemorrhagic shock . 7 . Patient hemoglobin &lt; 9 g/dl .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>